A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
Biomolecules · 05.07.2025 · 15 (7) · 967
DOI: 10.3390/biom15070967 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 05.07.2025. Verfasst von Benjamin Reardon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Joint Medical Program, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW 2145, Australia. Hauptthemen laut MEDLINE: Deamino Arginine Vasopressin, Hemostatics. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As a synthetic analogue of vasopressin, desmopressin or DDAVP has well established hemostatic properties. We present a review of DDAVP and summarize the clinical and laboratory evidence for its use in hemophilia A, von Willebrand disease (VWD), platelet function disorders, uremia, liver cirrhosis, and pregnancy, followed by illustrative examples of its broad efficacy from our local practice. In brief, DDAVP acts to release von Willebrand factor (VWF) and factor VIII from endogenously stored reserves, thereby correcting plasma deficiencies present in mild to moderately affected patients with hemophilia A and VWD. Thus, DDAVP represents a non-transfusional therapy for these disorders. Typically, a trial of DDAVP is arranged to assess individual responsiveness before employing DDAVP clinically, since there is individual variation in responsiveness. Thereafter, DDAVP can be utilized in responsive patients for clinical use and provides a factor replacement sparing strategy in these patients for some clinical situations. Nevertheless, DDAVP is best applied as a factor replacement sparing strategy, especially for minor procedures or short-term use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Medical Program, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW 2145, Australia.
- Haematology Department, Calvary Mater Hospital Newcastle, Waratah, NSW 2298, Australia.
- Haematology Department, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW 2145, Australia.
- Westmead Clinical School, University of Sydney, Westmead, NSW 2145, Australia.
- Sydney Centres for Thrombosis and Haemostasis, Research and Education Network (REN) and Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, NSW 2145, Australia.
- School of Dentistry and Medical Sciences, Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW 2650, Australia.
ORCID-Profile: Benjamin Reardon, Emmanuel J Favaloro
Zitieren
APA
Reardon, B., Pasalic, L., & Favaloro, E. J. (2025). A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?. Biomolecules, 15(7), 967. https://doi.org/10.3390/biom15070967
Vancouver
Reardon B, Pasalic L, Favaloro EJ. A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?. Biomolecules. 2025;15(7):967. doi:10.3390/biom15070967
BibTeX
@article{Reardon2025,
author = {Reardon, Benjamin and Pasalic, Leonardo and Favaloro, Emmanuel J},
title = {A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {7},
pages = {967},
doi = {10.3390/biom15070967}
}
EUVIMED